Marina Shokry, PHARM.D
Pharmacist · Irvine, CA
Marina Shokry, PHARM.D is a pharmacist with a practice address in Irvine, California, and NPI 1194449520, issued on Sep 29, 2022. Check the license (California 86345, as entered in NPPES) with the California board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Marina Shokry
- Credential
- PHARM.D
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 86345 CA
Self-reported in NPPES; status is on the state search - Practice location
- 9204 Esperanza, Irvine, CA 92618
- Phone
- (714) 454-6611
- Enumerated
- Sep 29, 2022
- Record last updated
- Sep 29, 2022
- Entity
- Type 1 · individual
Verify Marina Shokry in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich California board licenses this profession
Search for license 86345Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs
41 Medicare Part D claims for 38 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Arexvy19 claims
- Shingrix15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
284 pharmacist records list a practice address in Irvine
They are 284 of the 7,778 NPPES records with a practice address in Irvine, and 32,533 pharmacist records in California.
All 284 in Irvine → All 32,533 in California → Every provider in Irvine →
Other pharmacist records in California
- Caroline A-Haja, PHARM.D.San Pedro, CA1851664361
- Gayatri AachiLivermore, CA1235660754
- Adrian Karlos Aala, PHARMD, RPHHayward, CA1023955499
- Mahshid Aalam, PHARMDLos Angeles, CA1659086155
- Jaleh AaliiveliSan Ramon, CA1336629963
- Cassi Aarvig, RPHTracy, CA1023679941
- Meara Michi AbadOrange, CA1750181178
- Nader Abadier, RPHFontana, CA1326255647
- Samia Abadier, RPHFontana, CA1548742836
- Sandy Abadir, RPHChino Hills, CA1811644412
Common questions
What is Marina Shokry, PHARM.D's NPI number?
Marina Shokry, PHARM.D's National Provider Identifier (NPI) is 1194449520, issued on Sep 29, 2022. An NPI identifies a provider in billing; it is not a license.
Where is Marina Shokry, PHARM.D located?
The NPPES record lists a practice address at 9204 Esperanza, Irvine, CA, 92618. Phone: (714) 454-6611. Providers update this record themselves, so call before visiting.
How can I verify Marina Shokry, PHARM.D's license?
NPPES lists California license number 86345, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.
How much does Marina Shokry, PHARM.D prescribe under Medicare Part D?
In 2024, Marina Shokry, PHARM.D had 41 Medicare Part D claims for 38 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.